{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:49Z","timestamp":1786980109490,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["OFR-2025-1347"],"award-info":[{"award-number":["OFR-2025-1347"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-026-08338-x","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:50:55Z","timestamp":1772214655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unlocking ovarian rejuvenation with platelet-rich plasma: systematic review and proposed clinical framework for Controlled use in poor prognosis patients undergoing in vitro fertilisation"],"prefix":"10.1007","volume":"313","author":[{"given":"Arwa A.","family":"Alageel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"8338_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.fertnstert.2018.06.039","volume":"110","author":"GD Adamson","year":"2018","unstructured":"Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O et al (2018) International committee for monitoring assisted reproductive technology: world report on assisted reproductive technology, 2011. Fertil Steril 110:1067\u20131080. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.06.039","journal-title":"Fertil Steril"},{"key":"8338_CR2","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/S43032-021-00483-9","volume":"28","author":"A Aflatoonian","year":"2021","unstructured":"Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N (2021) Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci 28:2050\u20132059. https:\/\/doi.org\/10.1007\/S43032-021-00483-9","journal-title":"Reprod Sci"},{"key":"8338_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC et al (2016) A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril 105:1452\u20131453. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.02.005","journal-title":"Fertil Steril"},{"key":"8338_CR4","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.jse.2010.07.005","volume":"20","author":"E Anitua","year":"2011","unstructured":"Anitua E, S\u00e1nchez M, Orive G (2011) The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. J Shoulder Elbow Surg 20:e23\u2013e24. https:\/\/doi.org\/10.1016\/j.jse.2010.07.005","journal-title":"J Shoulder Elbow Surg"},{"key":"8338_CR5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/humrep\/deab106","volume":"36","author":"L Atkinson","year":"2021","unstructured":"Atkinson L, Martin F, Sturmey RG (2021) Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon? Hum Reprod 36:1737\u20131750. https:\/\/doi.org\/10.1093\/humrep\/deab106","journal-title":"Hum Reprod"},{"key":"8338_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac027","author":"DH Barad","year":"2022","unstructured":"Barad DH, Albertini DF, Molinari E, Gleicher N (2022) Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study. Hum Reprod Open. https:\/\/doi.org\/10.1093\/hropen\/hoac027","journal-title":"Hum Reprod Open"},{"key":"8338_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/PHM.0b013e3181f1c1c7","volume":"89","author":"P Borrione","year":"2010","unstructured":"Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F (2010) Platelet-rich plasma in muscle healing. Am J Phys Med Rehabil 89:854\u2013861. https:\/\/doi.org\/10.1097\/PHM.0b013e3181f1c1c7","journal-title":"Am J Phys Med Rehabil"},{"key":"8338_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa009","author":"E Bosch","year":"2020","unstructured":"Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E et al (2020) ESHRE guideline: ovarian stimulation for IVF\/ICSI\u2020. Hum Reprod Open. https:\/\/doi.org\/10.1093\/hropen\/hoaa009","journal-title":"Hum Reprod Open"},{"key":"8338_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/S10815-018-1159-8","volume":"35","author":"A Bos-Mikich","year":"2018","unstructured":"Bos-Mikich A, Oliveira RD, Frantz N (2018) Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet 35:753\u2013756. https:\/\/doi.org\/10.1007\/S10815-018-1159-8","journal-title":"J Assist Reprod Genet"},{"key":"8338_CR10","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.K.01501","volume":"94","author":"SR Browning","year":"2012","unstructured":"Browning SR, Weiser AM, Woolf N, Golish SR, SanGiovanni TP, Scuderi GJ et al (2012) Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg 94:e172. https:\/\/doi.org\/10.2106\/JBJS.K.01501","journal-title":"J Bone Joint Surg"},{"key":"8338_CR11","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/AGING.103403","volume":"12","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT et al (2020) Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging 12:10211\u201310222. https:\/\/doi.org\/10.18632\/AGING.103403","journal-title":"Aging"},{"key":"8338_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-6-33","volume":"6","author":"J Callejo","year":"2013","unstructured":"Callejo J, Salvador C, Gonz\u00e1lez-Nu\u00f1ez S, Almeida L, Rodriguez L, Marqu\u00e9s L et al (2013) Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors. J Ovarian Res 6:33. https:\/\/doi.org\/10.1186\/1757-2215-6-33","journal-title":"J Ovarian Res"},{"key":"8338_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41374-020-00513-1","volume":"101","author":"J Cho","year":"2021","unstructured":"Cho J, Kim T-H, Seok J, Jun JH, Park H, Kweon M et al (2021) Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway. Lab Invest 101:304\u2013317. https:\/\/doi.org\/10.1038\/s41374-020-00513-1","journal-title":"Lab Invest"},{"key":"8338_CR14","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","volume":"32","author":"J Cohen","year":"2015","unstructured":"Cohen J, Chabbert-Buffet N, Darai E (2015) Diminished ovarian reserve, premature ovarian failure, poor ovarian responder\u2014a plea for universal definitions. J Assist Reprod Genet 32:1709\u20131712. https:\/\/doi.org\/10.1007\/s10815-015-0595-y","journal-title":"J Assist Reprod Genet"},{"key":"8338_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.22088\/cjim.14.3.485","volume":"14","author":"F Davari tanha","year":"2023","unstructured":"Davari tanha F, Salimi Setudeh S, Ebrahimi M, Feizabad E, Khalaj Sereshki Z, Akbari Asbagh F et al (2023) Effect of intra-ovarian platelet rich plasma in women with poor ovarian response. Caspian J Intern Med 14:485\u2013489. https:\/\/doi.org\/10.22088\/cjim.14.3.485","journal-title":"Caspian J Intern Med"},{"key":"8338_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0974-2077.150734","volume":"7","author":"R Dhurat","year":"2014","unstructured":"Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author\u2032s perspective. J Cutan Aesthet Surg 7:189. https:\/\/doi.org\/10.4103\/0974-2077.150734","journal-title":"J Cutan Aesthet Surg"},{"key":"8338_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/2633494120941480","author":"P Drakopoulos","year":"2020","unstructured":"Drakopoulos P, Bardhi E, Boudry L, Vaiarelli A, Makrigiannakis A, Esteves SC et al (2020) Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept. Ther Adv Reprod Health. https:\/\/doi.org\/10.1177\/2633494120941480","journal-title":"Ther Adv Reprod Health"},{"key":"8338_CR18","doi-asserted-by":"publisher","unstructured":"(2016) ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. 31: 926\u2013937.https:\/\/doi.org\/10.1093\/humrep\/dew027","DOI":"10.1093\/humrep\/dew027"},{"key":"8338_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/humupd\/dmp005","volume":"15","author":"G Fanciulli","year":"2009","unstructured":"Fanciulli G, Delitala A, Delitala G (2009) Growth hormone, menopause and ageing: no definite evidence for \u201crejuvenation\u201d with growth hormone. Hum Reprod Update 15:341\u2013358. https:\/\/doi.org\/10.1093\/humupd\/dmp005","journal-title":"Hum Reprod Update"},{"key":"8338_CR20","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/S11033-019-04609-W","volume":"46","author":"M Farimani","year":"2019","unstructured":"Farimani M, Heshmati S, Poorolajal J, Bahmanzadeh M (2019) A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Mol Biol Rep 46:1611\u20131616. https:\/\/doi.org\/10.1007\/S11033-019-04609-W","journal-title":"Mol Biol Rep"},{"key":"8338_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00826-w","volume":"19","author":"M Farimani","year":"2021","unstructured":"Farimani M, Nazari A, Mohammadi S, Aliabad RA (2021) Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol 19:137. https:\/\/doi.org\/10.1186\/s12958-021-00826-w","journal-title":"Reprod Biol Endocrinol"},{"key":"8338_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L (2011) ESHRE consensus on the definition of \u2019poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26:1616\u20131624. https:\/\/doi.org\/10.1093\/humrep\/der092","journal-title":"Hum Reprod"},{"key":"8338_CR23","doi-asserted-by":"publisher","unstructured":"Ferrari AR, Cortrezzi S, Borges Junior E, Braga D, Souza MCB do de, Antunes RA de (2021). Evaluation of the effects of platelet-rich plasma on follicular and Endometrial growth: a literature review. JBRA Assist Reprod. https:\/\/doi.org\/10.5935\/1518-0557.20210036","DOI":"10.5935\/1518-0557.20210036"},{"key":"8338_CR24","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1177\/0363546509349921","volume":"37","author":"TE Foster","year":"2009","unstructured":"Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-Rich Plasma. Am J Sports Med 37:2259\u20132272. https:\/\/doi.org\/10.1177\/0363546509349921","journal-title":"Am J Sports Med"},{"key":"8338_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38674","author":"M Fraidakis","year":"2023","unstructured":"Fraidakis M, Giannakakis G, Anifantaki A, Skouradaki M, Tsakoumi P, Bitzopoulou P et al (2023) Intraovarian platelet-rich plasma injections: safety and thoughts on efficacy based on a single centre experience with 469 women. Cureus. https:\/\/doi.org\/10.7759\/cureus.38674","journal-title":"Cureus"},{"key":"8338_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/medicines10030019","volume":"10","author":"A Garavelas","year":"2023","unstructured":"Garavelas A, Mallis P, Michalopoulos E, Nikitos E (2023) Clinical benefit of autologous platelet-rich plasma infusion in ovarian function rejuvenation: evidence from a before-after prospective pilot study. Medicines 10:19. https:\/\/doi.org\/10.3390\/medicines10030019","journal-title":"Medicines"},{"key":"8338_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4103\/idoj.IDOJ_653_19","volume":"11","author":"V Gupta","year":"2020","unstructured":"Gupta V, Parihar A, Pathak M, Sharma V (2020) Comparison of platelet-rich plasma prepared using two methods: manual double spin method versus a commercially available automated device. Indian Dermatol Online J 11:575. https:\/\/doi.org\/10.4103\/idoj.IDOJ_653_19","journal-title":"Indian Dermatol Online J"},{"key":"8338_CR28","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928\u2013d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"8338_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/J.RBMO.2017.04.007","volume":"35","author":"L Hosseini","year":"2017","unstructured":"Hosseini L, Shirazi A, Naderi MM, Shams-Esfandabadi N, Borjian Boroujeni S, Sarvari A et al (2017) Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online 35:343\u2013350. https:\/\/doi.org\/10.1016\/J.RBMO.2017.04.007","journal-title":"Reprod Biomed Online"},{"key":"8338_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00050","author":"C-C Hsu","year":"2020","unstructured":"Hsu C-C, Hsu L, Hsu I, Chiu Y-J, Dorjee S (2020) Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.00050","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8338_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626924","author":"B Ishizuka","year":"2021","unstructured":"Ishizuka B (2021) Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI). Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.626924","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8338_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/NATURE02316","volume":"428","author":"J Johnson","year":"2004","unstructured":"Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL (2004) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428:145\u2013150. https:\/\/doi.org\/10.1038\/NATURE02316","journal-title":"Nature"},{"key":"8338_CR33","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v32i6.10","author":"F Keikha","year":"2022","unstructured":"Keikha F, Shahsavari S, Salari Y, Roozbeh N, Haghollahi F, Dehghan Tarazjani M et al (2022) One side ovarian rejuvenation: a quasi-experimental Study of the effect of the autologous platelet rich plasma in poor ovarian responders in IVF. Ethiop J Health Sci. https:\/\/doi.org\/10.4314\/ejhs.v32i6.10","journal-title":"Ethiop J Health Sci"},{"key":"8338_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/0378-6323.125467","volume":"80","author":"MS Kumaran","year":"2014","unstructured":"Kumaran MS, Arshdeep (2014) Platelet-rich plasma in dermatology: Boon or a bane? Indian J Dermatol Venereol Leprol. 80:5. https:\/\/doi.org\/10.4103\/0378-6323.125467","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"8338_CR35","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700\u2013b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"8338_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01498-x","volume":"15","author":"J Liu","year":"2025","unstructured":"Liu J, Qin Y, Liu H, Liu Y, Yang Y, Ning Y et al (2025) Global, regional, and national burden of female infertility and trends from 1990 to 2021 with projections to 2050 based on the GBD 2021 analysis. Sci Rep 15:17559. https:\/\/doi.org\/10.1038\/s41598-025-01498-x","journal-title":"Sci Rep"},{"key":"8338_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/09537104.2020.1832653","volume":"32","author":"J Magalon","year":"2021","unstructured":"Magalon J, Brandin T, Francois P, Degioanni C, De Maria L, Grimaud F et al (2021) Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine. Platelets 32:200\u2013208. https:\/\/doi.org\/10.1080\/09537104.2020.1832653","journal-title":"Platelets"},{"key":"8338_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/S10815-020-01710-Z","volume":"37","author":"P Melo","year":"2020","unstructured":"Melo P, Navarro C, Jones C, Coward K, Coleman L (2020) The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet 37:855\u2013863. https:\/\/doi.org\/10.1007\/S10815-020-01710-Z","journal-title":"J Assist Reprod Genet"},{"key":"8338_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4532179","volume":"2017","author":"G Mori","year":"2017","unstructured":"Mori G, Brunetti G, Mastrangelo F, Cavalcanti-Adam EA (2017) Targeting adult mesenchymal stem cells plasticity for tissue regeneration. Stem Cells Int 2017:1\u20132. https:\/\/doi.org\/10.1155\/2017\/4532179","journal-title":"Stem Cells Int"},{"key":"8338_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.22074\/IJFS.2021.533576.1154","volume":"16","author":"N Navali","year":"2022","unstructured":"Navali N, Sadeghi L, Farzadi L, Ghasemzadeh A, Hamdi K, Hakimi P et al (2022) Intraovarian injection of autologous platelet-rich plasma improves therapeutic approaches in the patients with poor ovarian response: a before-after study. Int J Fertil Steril 16:90\u201394. https:\/\/doi.org\/10.22074\/IJFS.2021.533576.1154","journal-title":"Int J Fertil Steril"},{"key":"8338_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJMcp0808697","volume":"360","author":"LM Nelson","year":"2009","unstructured":"Nelson LM (2009) Primary Ovarian Insufficiency. N Engl J Med 360:606\u2013614. https:\/\/doi.org\/10.1056\/NEJMcp0808697","journal-title":"N Engl J Med"},{"key":"8338_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.18632\/aging.100105","volume":"1","author":"Y Niikura","year":"2009","unstructured":"Niikura Y, Niikura T, Tilly JL (2009) Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging 1:971\u2013978. https:\/\/doi.org\/10.18632\/aging.100105","journal-title":"Aging"},{"key":"8338_CR43","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10848","volume":"22","author":"I Pacu","year":"2021","unstructured":"Pacu I, Zygouropoulos N, Dimitriu M, Rosu G, Ionescu C (2021) Use of platelet-rich plasma in the treatment of infertility in\u00a0poor responders in assisted human reproduction procedures. Exp Ther Med 22:1412. https:\/\/doi.org\/10.3892\/etm.2021.10848","journal-title":"Exp Ther Med"},{"key":"8338_CR44","first-page":"301","volume":"31","author":"K Pantos","year":"2016","unstructured":"Pantos K, Nitsos N, Kokkali G, Vaxevanoglou T, Markomichali C, Pantou A et al (2016) Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Hum Reprod 31:301","journal-title":"Hum Reprod"},{"key":"8338_CR45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/0963689719859539","volume":"28","author":"K Pantos","year":"2019","unstructured":"Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N et al (2019) A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following Platelet-Rich Plasma treatment. Cell Transplant 28:1333\u20131340. https:\/\/doi.org\/10.1177\/0963689719859539","journal-title":"Cell Transplant"},{"key":"8338_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/13102818.2022.2090280","volume":"36","author":"D Parvanov","year":"2022","unstructured":"Parvanov D, Ganeva R, Vidolova N, Nikolova K, Vasileva M, Totev T et al (2022) Autologous ovarian platelet rich plasma treatment improves oocyte and embryo quality: a before-after prospective study. Biotechnol Biotechnol Equip 36:425\u2013432. https:\/\/doi.org\/10.1080\/13102818.2022.2090280","journal-title":"Biotechnol Biotechnol Equip"},{"key":"8338_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coemr.2021.03.001","volume":"18","author":"BK Patton","year":"2021","unstructured":"Patton BK, Madadi S, Pangas SA (2021) Control of ovarian follicle development by TGF-\u03b2 family signaling. Curr Opin Endocr Metab Res 18:102\u2013110. https:\/\/doi.org\/10.1016\/j.coemr.2021.03.001","journal-title":"Curr Opin Endocr Metab Res"},{"key":"8338_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18413\/rrpharmacology.10.437","volume":"10","author":"VN Perfilova","year":"2024","unstructured":"Perfilova VN, Muzyko EA, Tikhaeva KY, Kustova MV, Mukhina AV, Fokina AY et al (2024) Assessment of VEGF and TNF-alpha levels in patients with an unexpectedly poor and suboptimal response during the treatment of infertility using ART methods. Res Results Pharmacol 10:1\u20139. https:\/\/doi.org\/10.18413\/rrpharmacology.10.437","journal-title":"Res Results Pharmacol"},{"key":"8338_CR49","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s43032-020-00266-8","volume":"27","author":"N Petryk","year":"2020","unstructured":"Petryk N, Petryk M (2020) Ovarian rejuvenation through Platelet-Rich autologous plasma (PRP)\u2014a chance to have a baby without donor eggs, improving the life quality of women suffering from early menopause without synthetic hormonal treatment. Reprod Sci 27:1975\u20131982. https:\/\/doi.org\/10.1007\/s43032-020-00266-8","journal-title":"Reprod Sci"},{"key":"8338_CR50","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.jomfp_93_18","volume":"22","author":"S Ramaswamy Reddy","year":"2018","unstructured":"Ramaswamy Reddy S, Reddy R, Babu Nc, Ashok G (2018) Stem-cell therapy and platelet-rich plasma in regenerative medicines: a review on pros and cons of the technologies. J Oral Maxillofac Pathol 22:367. https:\/\/doi.org\/10.4103\/jomfp.jomfp_93_18","journal-title":"J Oral Maxillofac Pathol"},{"key":"8338_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/GCO.0000000000000703","volume":"33","author":"A Reig","year":"2021","unstructured":"Reig A, Herraiz S, Pellicer A, Seli E (2021) Emerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency. Curr Opin Obstet Gynecol 33:241\u2013248. https:\/\/doi.org\/10.1097\/GCO.0000000000000703","journal-title":"Curr Opin Obstet Gynecol"},{"key":"8338_CR52","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/11011.5536","author":"R Sabarish","year":"2015","unstructured":"Sabarish R (2015) A comparison of platelet count and enrichment percentages in the platelet rich plasma (PRP) obtained following preparation by three different methods. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/JCDR\/2015\/11011.5536","journal-title":"J Clin Diagn Res"},{"key":"8338_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.103149","author":"R Sabouni","year":"2022","unstructured":"Sabouni R, Tarrab R, kalaji D, Abbassi H (2022) A new approach of using platelet-rich autologous plasma to increase the ovarian reservoir in a Syrian patient with ovarian insufficiency: a case report. Ann Med Surg. https:\/\/doi.org\/10.1016\/j.amsu.2021.103149","journal-title":"Ann Med Surg"},{"key":"8338_CR54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.18502\/ijrm.v18i12.8030","volume":"18","author":"E Scott Sills","year":"2020","unstructured":"Scott Sills E, Rickers NS, Wood SH (2020) Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: fertility recovery and first unassisted conception with term delivery at age over 40. Int J Reprod BioMed (IJRM) 18:1081\u20131086. https:\/\/doi.org\/10.18502\/ijrm.v18i12.8030","journal-title":"Int J Reprod BioMed (IJRM)"},{"key":"8338_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061809","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Simopoulou M, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E et al (2020) Clinical medicine reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency perimenopausal, menopausal, and poor responder women. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9061809","journal-title":"J Clin Med"},{"key":"8338_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000491697","volume":"84","author":"K Sfakianoudis","year":"2019","unstructured":"Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pantou A, Vaxevanoglou T et al (2019) A case series on platelet-rich plasma revolutionary management of poor responder patients. Gynecol Obstet Invest 84:99\u2013106. https:\/\/doi.org\/10.1159\/000491697","journal-title":"Gynecol Obstet Invest"},{"key":"8338_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010001","volume":"8","author":"K Sfakianoudis","year":"2018","unstructured":"Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pappas A, Pantou A et al (2018) Autologous platelet-rich plasma treatment enables pregnancy for a woman in premature menopause. J Clin Med 8:1. https:\/\/doi.org\/10.3390\/jcm8010001","journal-title":"J Clin Med"},{"key":"8338_CR58","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/09513590.2018.1445219","volume":"34","author":"ES Sills","year":"2018","unstructured":"Sills ES, Rickers NS, Li X, Palermo GD (2018) First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol 34:756\u2013760. https:\/\/doi.org\/10.1080\/09513590.2018.1445219","journal-title":"Gynecol Endocrinol"},{"key":"8338_CR59","unstructured":"Sills ES, Rickers NS, Svid CS, Rickers JM, Wood SH (2019) I IJ JM MC CM M case report normalized ploidy following 20 consecutive blastocysts with chromosomal error: healthy 46, XY pregnancy with IVF after Intraovarian injection of autologous enriched platelet-derived growth factors"},{"key":"8338_CR60","doi-asserted-by":"publisher","DOI":"10.31487\/j.rgm.2020.01.02","author":"ES Sills","year":"2020","unstructured":"Sills ES, Sills ES, Petersen JL, Rickers NS, Wood SH, Li X (2020) Regenerative effect of intraovarian injection of activated autologous platelet rich plasma: serum anti-mullerian hormone levels measured among poor-prognosis in vitro fertilization patients. Int J Regen Med. https:\/\/doi.org\/10.31487\/j.rgm.2020.01.02","journal-title":"Int J Regen Med"},{"key":"8338_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196275","volume":"12","author":"M Skowro\u0144ska","year":"2023","unstructured":"Skowro\u0144ska M, Paw\u0142owski M, Milewski R (2023) A literature review and a proposed classification of the relationships between ovulatory infertility and lifestyle factors based on the three groups of ovulation disorders classified by WHO. J Clin Med 12:6275. https:\/\/doi.org\/10.3390\/jcm12196275","journal-title":"J Clin Med"},{"key":"8338_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"8338_CR63","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","volume":"39","author":"EA Sundman","year":"2011","unstructured":"Sundman EA, Cole BJ, Fortier LA (2011) Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39:2135\u20132140. https:\/\/doi.org\/10.1177\/0363546511417792","journal-title":"Am J Sports Med"},{"key":"8338_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/humupd\/dmg007","volume":"9","author":"BC Tarlatzis","year":"2003","unstructured":"Tarlatzis BC (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9:61\u201376. https:\/\/doi.org\/10.1093\/humupd\/dmg007","journal-title":"Hum Reprod Update"},{"key":"8338_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4274\/jtgga.galenos.2021.2021.0134","volume":"23","author":"F T\u00fclek","year":"2022","unstructured":"T\u00fclek F, Kahraman A (2022) The effects of intra-ovarian autologous platelet rich plasma injection on IVF outcomes of poor responder women and women with premature ovarian insufficiency. J Turk Ger Gynecol Assoc 23:14\u201321. https:\/\/doi.org\/10.4274\/jtgga.galenos.2021.2021.0134","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"8338_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/humupd\/5.5.483","volume":"5","author":"YM Van Kasteren","year":"1999","unstructured":"Van Kasteren YM, Schoemaker J (1999) Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483","journal-title":"Hum Reprod Update"},{"key":"8338_CR67","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1432-0436.2008.00268.x","volume":"76","author":"I Virant-Klun","year":"2008","unstructured":"Virant-Klun I, Zech N, Ro\u017eman P, Vogler A, Cvjeti\u010danin B, Klemenc P et al (2008) Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation 76:843\u2013856. https:\/\/doi.org\/10.1111\/j.1432-0436.2008.00268.x","journal-title":"Differentiation"},{"key":"8338_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01272-5","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao X, Luo R, Xia D, Liu Y, Shen T et al (2023) The causal association between systemic inflammatory regulators and primary ovarian insufficiency: a bidirectional mendelian randomization study. J Ovarian Res 16:191. https:\/\/doi.org\/10.1186\/s13048-023-01272-5","journal-title":"J Ovarian Res"},{"key":"8338_CR69","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nm.2669","volume":"18","author":"YAR White","year":"2012","unstructured":"White YAR, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL (2012) Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 18:413\u2013421. https:\/\/doi.org\/10.1038\/nm.2669","journal-title":"Nat Med"},{"key":"8338_CR70","unstructured":"(2023) World Health Organization. Infertility prevalence estimates, 1990\u20132021. WHO, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9789240076644. Accessed 24 Sep 2025"},{"key":"8338_CR71","first-page":"2510","volume":"14","author":"Y Cakiroglu","year":"2022","unstructured":"Cakiroglu Y, Yuceturk A, Karaosmanoglu O, Kopuk SY, Korun ZEU, Herlihy N et al (2022) Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging (Albany NY) 14:2510","journal-title":"Aging (Albany NY)"},{"key":"8338_CR72","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.fertnstert.2009.09.009","volume":"92","author":"F Zegers-Hochschild","year":"2009","unstructured":"Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K et al (2009) International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009\u2217. Fertil Steril 92:1520\u20131524. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.09.009","journal-title":"Fertil Steril"},{"key":"8338_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1506229","author":"G Zeng","year":"2025","unstructured":"Zeng G, Liu L, Wang Y, Yu J, Wang H, Li F (2025) Global, regional, and national burden and trends of reproductive-aged male and female infertility from 1990\u20132021. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2025.1506229","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08338-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:50:58Z","timestamp":1772214658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8338"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08338-x","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"112"}}